Literature DB >> 24489418

Rejoinder to comments on Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer.

Lu Wang, Andrea Rotnitzky, Xihong Lin, Randall E Millikan, Peter F Thall.   

Abstract

Entities:  

Year:  2012        PMID： 24489418      PMCID： PMC3908914          DOI： 10.1080/01621459.2012.665198

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN： 0162-1459            Impact factor:   5.033


× No keyword cloud information.
  10 in total

1.  Comment: improved local efficiency and double robustness.

Authors:  Zhiqiang Tan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

2.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

3.  Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoring.

Authors:  Peter F Thall; Leiko H Wooten; Christopher J Logothetis; Randall E Millikan; Nizar M Tannir
Journal:  Stat Med       Date:  2007-11-20       Impact factor: 2.373

4.  Improved double-robust estimation in missing data and causal inference models.

Authors:  Andrea Rotnitzky; Quanhong Lei; Mariela Sued; James M Robins
Journal:  Biometrika       Date:  2012-04-29       Impact factor: 2.445

5.  Toward a curse of dimensionality appropriate (CODA) asymptotic theory for semi-parametric models.

Authors:  J M Robins; Y Ritov
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

6.  SMART Design Issues and the Consideration of Opposing Outcomes: Discussion of "Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer" by by Wang, Rotnitzky, Lin, Millikan, and Thall.

Authors:  Daniel Almirall; Daniel J Lizotte; Susan A Murphy
Journal:  J Am Stat Assoc       Date:  2012-04-27       Impact factor: 5.033

Review 7.  Quality adjusted survival analysis.

Authors:  P P Glasziou; R J Simes; R D Gelber
Journal:  Stat Med       Date:  1990-11       Impact factor: 2.373

8.  Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data.

Authors:  Weihua Cao; Anastasios A Tsiatis; Marie Davidian
Journal:  Biometrika       Date:  2009-08-07       Impact factor: 2.445

9.  Dose-finding based on efficacy-toxicity trade-offs.

Authors:  Peter F Thall; John D Cook
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

10.  Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase I/II trials.

Authors:  Nadine Houede; Peter F Thall; Hoang Nguyen; Xavier Paoletti; Andrew Kramar
Journal:  Biometrics       Date:  2009-08-10       Impact factor: 2.571
  10 in total
  2 in total

1.  Targeted maximum likelihood estimation for dynamic treatment regimes in sequentially randomized controlled trials.

Authors:  Paul H Chaffee; Mark J van der Laan
Journal:  Int J Biostat       Date:  2012-06-22       Impact factor: 0.968

2.  SMARTer discontinuation trial designs for developing an adaptive treatment strategy.

Authors:  Daniel Almirall; Scott N Compton; Moira A Rynn; John T Walkup; Susan A Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-10       Impact factor: 2.576
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.